会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • 2-Substituted adenosine-5{40 {0 carboxylates
    • 2-取代腺苷-5 {40 {0羧酸盐
    • US3903073A
    • 1975-09-02
    • US42851673
    • 1973-12-26
    • ABBOTT LAB
    • PRASAD RAJ NANDANSTEIN HERMAN HALTIETJE KARIN ROSEMARIE
    • C07H19/16C07H19/18
    • C07H19/16
    • WHEREIN R is amino, acetamido or hydroxy, R1 is loweralkyl, haloloweralkyl, hydroxyloweralkyl, lowercycloalkyl, loweralkenyl, loweralkynyl, loweralkyl(C3-C6)cycloalkyl or alkoxyalkyl and R2 and R3 each are hydrogen or acyl, or R2 and R3 taken together form an isopropylidene or benzylidene moiety; and the pharmaceutically acceptable acid addition salts thereof. The compounds wherein R2 and R3 are hydrogen or acyl are useful in treating cardiovascular disorders and are particularly useful as anti-anginal agents. Compounds wherein R2 and R3 when taken together form an isopropylidene or benzylidene moiety are intermediates useful in making the final products.
      2-Substituted adenosine-5''-carboxylates represented by the formula
    • 由式WHEREIN R表示的2-取代的腺苷-5'-羧酸盐,乙酰氨基或羟基,R 1是低级烷基,卤代低级烷基,羟基低级烷基,低级环烷基,低级烯基,低级炔基,低级烷基(C 3 -C 6)环烷基或烷氧基烷基,R 2和R 3各自 是氢或酰基,或者R 2和R 3一起形成异亚丙基或亚苄基部分; 及其药学上可接受的酸加成盐。 其中R2和R3是氢或酰基的化合物可用于治疗心血管疾病,并且特别可用作抗心绞痛剂。 其中R2和R3一起形成异亚丙基或亚苄基部分的化合物是可用于制备最终产物的中间体。